Success Metrics

Clinical Success Rate
100.0%

Based on 19 completed trials

Completion Rate
100%(19/19)
Active Trials
1(5%)
Results Posted
53%(10 trials)

Phase Distribution

Ph phase_2
2
10%
Ph phase_3
3
15%
Ph phase_4
1
5%
Ph not_applicable
14
70%

Phase Distribution

0

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution20 total trials
Phase 2Efficacy & side effects
2(10.0%)
Phase 3Large-scale testing
3(15.0%)
Phase 4Post-market surveillance
1(5.0%)
N/ANon-phased studies
14(70.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

19 of 19 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

20

all time

Status Distribution
Active(1)
Completed(19)

Detailed Status

Completed19
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
20
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (10.0%)
Phase 33 (15.0%)
Phase 41 (5.0%)
N/A14 (70.0%)

Trials by Status

active_not_recruiting15%
completed1995%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT07367204Not Applicable

Randomized Masked Trial of Injectable Cross-Linked Hyaluronic Acid for Moderate-to-Severe Nasolabial Folds

Active Not Recruiting
NCT03003130Not Applicable

Restylane Defyne Compared to Restylane for Correction of Moderate to Severe Nasolabial Folds

Completed
NCT05935501Not Applicable

Clinical Trial of Cross-linked Hyaluronic Acid Dermal Filler

Completed
NCT02918721Not Applicable

Pain and Safety of Restylane With and Without Lidocaine for Correction of Moderate and Severe Nasolabial Folds

Completed
NCT02432742Not Applicable

Efficacy and Safety of Restylane Perlane Compared to Restylane for Correction of Moderate and Severe Nasolabial Folds

Completed
NCT02565784Not Applicable

Safety and Efficacy of Restylane Lidocaine and Restylane Perlane Lidocaine for Facial Augmentation in Asian Population

Completed
NCT02179736Not Applicable

A Post Market Evaluation After Treatment of Nasolabial Folds

Completed
NCT04486794Not Applicable

Restylane® for the Treatment of Tear Trough Deformity

Completed
NCT01797432Phase 2

Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata

Completed
NCT03738020Not Applicable

Clinical Study to Evaluate the Correction of Wrinkles and Folds and Safety of YVOIRE Classic Versus Restylane in Nasolabial Fold Intradermal Injection

Completed
NCT02987205Not Applicable

Multicenter Double-Blind Randomized Split-Face Study to Evaluate Revanesse® Ultra vs Restylane® for Correction of NLF

Completed
NCT02558283Not Applicable

A Safety and Efficacy Study of JUVÉDERM® VOLIFT® With Lidocaine and Restylane® for Nasolabial Folds in Chinese Adults

Completed
NCT00444626Phase 3

A Study to Compare the Safety and Effectiveness of a Non-FDA Approved Device Dermal Gel Extra (DGE) and an FDA Approved Device for the Correction of Nasolabial Folds (NLFs)

Completed
NCT02179619Phase 3

Clinical Study to Evaluate the Efficacy and Safety of Dermalax(Deep) in Correction of Nasolabial Folds

Completed
NCT01940575Not Applicable

Efficacy and Safety Study of SkinPlus-Hyal® to Nasolabial Fold

Completed
NCT00935272Not Applicable

Safety/Efficacy Study of Restylane® in Lip Augmentation

Completed
NCT00764257Phase 3

PREVELLE Shape (CX002) Dermal Filler Protocol

Completed
NCT00765583Phase 4

A Study to Determine How Long Restylane® Will Last After Initial Treatment With 2 Different Re-treatment Schedules.

Completed
NCT00414544Phase 2

Evaluation of the Safety and Efficacy of CosmetaLife™ for the Correction of Nasolabial Folds

Completed
NCT00407914Not Applicable

Safety and Effectiveness of Aquamid as Compared to Restylane for the Aesthetic Treatment of Nasolabial Folds

Completed

All 20 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
20